Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Gastrointestinal Cancer|Breast Cancer
Interventions: DEVICE: QPOP|DEVICE: CURATE.AI|DRUG: Azacitidine + docetaxel|DRUG: Azacitidine + paclitaxel|DRUG: Azacitidine + irinotecan
Sponsor: National University Hospital, Singapore
Collaborators: The N.1 Institute for Health (N.1)|Cancer Science Institute of Singapore